Product Code: ETC13182291 | Publication Date: Apr 2025 | Updated Date: Jul 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | Author: Shubham Deep | No. of Pages: 190 | No. of Figures: 80 | No. of Tables: 40 |
According to 6Wresearch internal database and industry insights, the Global Plasma Fractionation Market was valued at USD 28 Billion in 2024 and is expected to reach USD 40 Billion by 2031, growing at a compound annual growth rate of 5.20% during the forecast period (2025-2031).
The global plasma fractionation market is experiencing steady growth driven by increasing demand for plasma-derived products in the healthcare industry. Plasma fractionation involves separating plasma into its individual components to produce therapeutically valuable proteins such as immunoglobulins, albumin, and clotting factors. Factors contributing to market growth include rising prevalence of immunodeficiency disorders, autoimmune diseases, and bleeding disorders, as well as a growing geriatric population. Additionally, advancements in fractionation technologies, expanding applications of plasma products, and increasing awareness about the benefits of plasma-derived therapies are further fueling market expansion. Geographically, North America and Europe dominate the market due to well-established healthcare infrastructure and high adoption rates of plasma-derived products, while the Asia-Pacific region is expected to witness significant growth opportunities due to improving healthcare facilities and increasing healthcare expenditure.
The Global Plasma Fractionation Market is witnessing significant growth driven by the increasing prevalence of immune deficiency disorders and autoimmune diseases, coupled with the rising demand for plasma-derived therapies. The market is also benefiting from advancements in technology, such as the development of novel plasma fractionation techniques and the introduction of new products. Additionally, the growing geriatric population and the expanding applications of plasma-derived therapies in various medical conditions are creating opportunities for market expansion. Companies are focusing on strategic collaborations, mergers, and acquisitions to strengthen their market presence and expand their product portfolios. Overall, the Global Plasma Fractionation Market is poised for continued growth with a favorable outlook for innovation and market expansion in the coming years.
The Global Plasma Fractionation Market faces several challenges, including stringent regulations and quality control requirements, high cost associated with plasma fractionation processes, and limited availability of plasma donors. Regulatory hurdles can impact market entry for new players and increase compliance costs for existing manufacturers. The complex and time-consuming nature of plasma fractionation processes contributes to the high production costs, which can ultimately affect pricing and market competitiveness. Additionally, the reliance on a limited pool of plasma donors poses a risk to the supply chain stability, potentially leading to shortages and affecting overall market growth. Addressing these challenges requires innovative solutions, collaboration among industry stakeholders, and investment in research and development to improve efficiency and overcome barriers to market expansion.
The Global Plasma Fractionation Market is primarily driven by the increasing prevalence of immune deficiency disorders, rising geriatric population, advancements in plasma fractionation technologies, and growing demand for plasma-derived therapies. The rising incidence of autoimmune diseases and chronic conditions, coupled with the expanding applications of plasma-derived products in various medical treatments, further contribute to the market growth. Additionally, the growing awareness about the benefits of plasma fractionation in treating rare diseases and the expanding healthcare infrastructure in emerging economies are key factors driving market expansion. Moreover, the ongoing research and development activities aimed at developing novel plasma-derived products and therapies are expected to fuel market growth in the coming years.
Government policies related to the Global Plasma Fractionation Market vary across countries but generally focus on ensuring the safety, quality, and availability of blood plasma products. Regulatory bodies such as the FDA in the United States and the EMA in Europe set standards for the collection, processing, and distribution of plasma-derived products to safeguard public health. These policies include strict guidelines for donor screening, testing, and manufacturing processes to prevent the transmission of infectious diseases and ensure product efficacy. Additionally, some governments may regulate pricing and reimbursement schemes to promote affordability and accessibility of plasma-derived therapies for patients. Overall, government policies play a crucial role in shaping the regulatory landscape of the plasma fractionation market and ensuring the supply of safe and effective products to meet healthcare needs.
The Global Plasma Fractionation Market is poised for significant growth in the coming years due to the increasing prevalence of chronic and rare diseases, rising geriatric population, and advancements in biotechnology. The market is expected to be driven by the growing demand for plasma-derived therapies, such as immunoglobulins, albumin, and clotting factors, for the treatment of various conditions, including immune deficiencies, neurological disorders, and hemophilia. Additionally, the expanding applications of plasma fractionation in regenerative medicine and drug development are likely to further fuel market expansion. However, regulatory challenges, ethical concerns regarding plasma collection, and the high cost of plasma-derived products may present obstacles to market growth. Overall, technological innovations, strategic collaborations, and expanding healthcare infrastructure globally are expected to sustain the growth trajectory of the Global Plasma Fractionation Market.
In the Global Plasma Fractionation Market, North America holds a significant share due to a well-established healthcare infrastructure and high adoption of advanced medical technologies. Europe follows closely behind, driven by increasing government initiatives for plasma fractionation research and development. Asia Pacific is anticipated to witness robust growth with a rising geriatric population and increasing awareness about plasma-derived therapies. The Middle East and Africa region is expected to show steady growth as healthcare infrastructure continues to improve. Latin America is also projected to experience growth, supported by expanding healthcare facilities and a growing demand for plasma-derived products. Overall, the global plasma fractionation market is poised for expansion across all regions, driven by advancements in healthcare technology and increasing prevalence of chronic diseases.
Global Plasma Fractionation Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Global Plasma Fractionation Market Overview |
3.1 Global Regional Macro Economic Indicators |
3.2 Global Plasma Fractionation Market Revenues & Volume, 2021 & 2031F |
3.3 Global Plasma Fractionation Market - Industry Life Cycle |
3.4 Global Plasma Fractionation Market - Porter's Five Forces |
3.5 Global Plasma Fractionation Market Revenues & Volume Share, By Regions, 2021 & 2031F |
3.6 Global Plasma Fractionation Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.7 Global Plasma Fractionation Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.8 Global Plasma Fractionation Market Revenues & Volume Share, By End-User, 2021 & 2031F |
4 Global Plasma Fractionation Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Global Plasma Fractionation Market Trends |
6 Global Plasma Fractionation Market, 2021 - 2031 |
6.1 Global Plasma Fractionation Market, Revenues & Volume, By Product Type, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 Global Plasma Fractionation Market, Revenues & Volume, By Immunoglobulin, 2021 - 2031 |
6.1.3 Global Plasma Fractionation Market, Revenues & Volume, By Coagulation Factor Concentrates, 2021 - 2031 |
6.1.4 Global Plasma Fractionation Market, Revenues & Volume, By Albumin, 2021 - 2031 |
6.1.5 Global Plasma Fractionation Market, Revenues & Volume, By Protease Inhibitors, 2021 - 2031 |
6.1.6 Global Plasma Fractionation Market, Revenues & Volume, By Other Plasma Products, 2021 - 2031 |
6.2 Global Plasma Fractionation Market, Revenues & Volume, By Application, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 Global Plasma Fractionation Market, Revenues & Volume, By Neurology, 2021 - 2031 |
6.2.3 Global Plasma Fractionation Market, Revenues & Volume, By Immunology, 2021 - 2031 |
6.2.4 Global Plasma Fractionation Market, Revenues & Volume, By Hematology, 2021 - 2031 |
6.2.5 Global Plasma Fractionation Market, Revenues & Volume, By Critical Care, 2021 - 2031 |
6.2.6 Global Plasma Fractionation Market, Revenues & Volume, By Pulmonology, 2021 - 2031 |
6.2.7 Global Plasma Fractionation Market, Revenues & Volume, By Others, 2021 - 2031 |
6.3 Global Plasma Fractionation Market, Revenues & Volume, By End-User, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 Global Plasma Fractionation Market, Revenues & Volume, By Hospitals and Clinics, 2021 - 2031 |
6.3.3 Global Plasma Fractionation Market, Revenues & Volume, By Clinical Research Laboratories, 2021 - 2031 |
6.3.4 Global Plasma Fractionation Market, Revenues & Volume, By Academic Institutes, 2021 - 2031 |
7 North America Plasma Fractionation Market, Overview & Analysis |
7.1 North America Plasma Fractionation Market Revenues & Volume, 2021 - 2031 |
7.2 North America Plasma Fractionation Market, Revenues & Volume, By Countries, 2021 - 2031 |
7.2.1 United States (US) Plasma Fractionation Market, Revenues & Volume, 2021 - 2031 |
7.2.2 Canada Plasma Fractionation Market, Revenues & Volume, 2021 - 2031 |
7.2.3 Rest of North America Plasma Fractionation Market, Revenues & Volume, 2021 - 2031 |
7.3 North America Plasma Fractionation Market, Revenues & Volume, By Product Type, 2021 - 2031 |
7.4 North America Plasma Fractionation Market, Revenues & Volume, By Application, 2021 - 2031 |
7.5 North America Plasma Fractionation Market, Revenues & Volume, By End-User, 2021 - 2031 |
8 Latin America (LATAM) Plasma Fractionation Market, Overview & Analysis |
8.1 Latin America (LATAM) Plasma Fractionation Market Revenues & Volume, 2021 - 2031 |
8.2 Latin America (LATAM) Plasma Fractionation Market, Revenues & Volume, By Countries, 2021 - 2031 |
8.2.1 Brazil Plasma Fractionation Market, Revenues & Volume, 2021 - 2031 |
8.2.2 Mexico Plasma Fractionation Market, Revenues & Volume, 2021 - 2031 |
8.2.3 Argentina Plasma Fractionation Market, Revenues & Volume, 2021 - 2031 |
8.2.4 Rest of LATAM Plasma Fractionation Market, Revenues & Volume, 2021 - 2031 |
8.3 Latin America (LATAM) Plasma Fractionation Market, Revenues & Volume, By Product Type, 2021 - 2031 |
8.4 Latin America (LATAM) Plasma Fractionation Market, Revenues & Volume, By Application, 2021 - 2031 |
8.5 Latin America (LATAM) Plasma Fractionation Market, Revenues & Volume, By End-User, 2021 - 2031 |
9 Asia Plasma Fractionation Market, Overview & Analysis |
9.1 Asia Plasma Fractionation Market Revenues & Volume, 2021 - 2031 |
9.2 Asia Plasma Fractionation Market, Revenues & Volume, By Countries, 2021 - 2031 |
9.2.1 India Plasma Fractionation Market, Revenues & Volume, 2021 - 2031 |
9.2.2 China Plasma Fractionation Market, Revenues & Volume, 2021 - 2031 |
9.2.3 Japan Plasma Fractionation Market, Revenues & Volume, 2021 - 2031 |
9.2.4 Rest of Asia Plasma Fractionation Market, Revenues & Volume, 2021 - 2031 |
9.3 Asia Plasma Fractionation Market, Revenues & Volume, By Product Type, 2021 - 2031 |
9.4 Asia Plasma Fractionation Market, Revenues & Volume, By Application, 2021 - 2031 |
9.5 Asia Plasma Fractionation Market, Revenues & Volume, By End-User, 2021 - 2031 |
10 Africa Plasma Fractionation Market, Overview & Analysis |
10.1 Africa Plasma Fractionation Market Revenues & Volume, 2021 - 2031 |
10.2 Africa Plasma Fractionation Market, Revenues & Volume, By Countries, 2021 - 2031 |
10.2.1 South Africa Plasma Fractionation Market, Revenues & Volume, 2021 - 2031 |
10.2.2 Egypt Plasma Fractionation Market, Revenues & Volume, 2021 - 2031 |
10.2.3 Nigeria Plasma Fractionation Market, Revenues & Volume, 2021 - 2031 |
10.2.4 Rest of Africa Plasma Fractionation Market, Revenues & Volume, 2021 - 2031 |
10.3 Africa Plasma Fractionation Market, Revenues & Volume, By Product Type, 2021 - 2031 |
10.4 Africa Plasma Fractionation Market, Revenues & Volume, By Application, 2021 - 2031 |
10.5 Africa Plasma Fractionation Market, Revenues & Volume, By End-User, 2021 - 2031 |
11 Europe Plasma Fractionation Market, Overview & Analysis |
11.1 Europe Plasma Fractionation Market Revenues & Volume, 2021 - 2031 |
11.2 Europe Plasma Fractionation Market, Revenues & Volume, By Countries, 2021 - 2031 |
11.2.1 United Kingdom Plasma Fractionation Market, Revenues & Volume, 2021 - 2031 |
11.2.2 Germany Plasma Fractionation Market, Revenues & Volume, 2021 - 2031 |
11.2.3 France Plasma Fractionation Market, Revenues & Volume, 2021 - 2031 |
11.2.4 Rest of Europe Plasma Fractionation Market, Revenues & Volume, 2021 - 2031 |
11.3 Europe Plasma Fractionation Market, Revenues & Volume, By Product Type, 2021 - 2031 |
11.4 Europe Plasma Fractionation Market, Revenues & Volume, By Application, 2021 - 2031 |
11.5 Europe Plasma Fractionation Market, Revenues & Volume, By End-User, 2021 - 2031 |
12 Middle East Plasma Fractionation Market, Overview & Analysis |
12.1 Middle East Plasma Fractionation Market Revenues & Volume, 2021 - 2031 |
12.2 Middle East Plasma Fractionation Market, Revenues & Volume, By Countries, 2021 - 2031 |
12.2.1 Saudi Arabia Plasma Fractionation Market, Revenues & Volume, 2021 - 2031 |
12.2.2 UAE Plasma Fractionation Market, Revenues & Volume, 2021 - 2031 |
12.2.3 Turkey Plasma Fractionation Market, Revenues & Volume, 2021 - 2031 |
12.3 Middle East Plasma Fractionation Market, Revenues & Volume, By Product Type, 2021 - 2031 |
12.4 Middle East Plasma Fractionation Market, Revenues & Volume, By Application, 2021 - 2031 |
12.5 Middle East Plasma Fractionation Market, Revenues & Volume, By End-User, 2021 - 2031 |
13 Global Plasma Fractionation Market Key Performance Indicators |
14 Global Plasma Fractionation Market - Export/Import By Countries Assessment |
15 Global Plasma Fractionation Market - Opportunity Assessment |
15.1 Global Plasma Fractionation Market Opportunity Assessment, By Countries, 2021 & 2031F |
15.2 Global Plasma Fractionation Market Opportunity Assessment, By Product Type, 2021 & 2031F |
15.3 Global Plasma Fractionation Market Opportunity Assessment, By Application, 2021 & 2031F |
15.4 Global Plasma Fractionation Market Opportunity Assessment, By End-User, 2021 & 2031F |
16 Global Plasma Fractionation Market - Competitive Landscape |
16.1 Global Plasma Fractionation Market Revenue Share, By Companies, 2024 |
16.2 Global Plasma Fractionation Market Competitive Benchmarking, By Operating and Technical Parameters |
17 Top 10 Company Profiles |
18 Recommendations |
19 Disclaimer |